-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Agilon Health, Raises Price Target to $140

Benzinga·08/06/2026 15:40:32
Listen to the news
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $95 to $140.